Pay in 4 interest-free payments of $6.88 Learn more
Ships within 48 hours · Estimated delivery Oct 24 - Oct 29
Based on TRIUMPH-4 and expected 2026 trial readouts, analysts project NDA submission in Q4 2026 or Q1 2027, FDA approval in mid-to-late 2027, and commercial launch in early 2028
People with LADA may be initially classified as having type 2 diabetes because of the age of onset
In this guide, you can find out more about how retatrutide works, what the latest research says, the potential side effects, and how it compares to other popular weight loss injections, such as Mounjaro and Wegovy
The brand name is the initials of the founders five daughters, pronounced like courage
Some people notice a change within days, while for others it fades more gradually over weeks
US$ 23.00
US$ 22.76
US$ 20.12
US$ 23.21
US$ 20.90
US$ 25.74
